• Medical_Professionals
• Medical_students
• Nurses

Following 5 years of success, the 6th Annual World Orphan Drug Congress USA  is once again gearing up to bring together stakeholders from all over the world. From humble beginnings as a small conference that brought together the few pioneers spearheading the progress in orphan drugs development it became known as the event that brought this community together. It is testament to how the industry has grown that now there are 3 simultaneous conference streams and an exhibition hall of over 40 stands at the Washington Hilton in D.C. 

In 2015, World Orphan Drug Congress USA was packed with great content on sustainability, pricing & reimbursement, commercialization and market access. To grow the breadth of the event even further and empower patient groups like never before, we launched Rare Disease Advocacy World . Pitch & Partner also grew from 20 to 40 presenters, making this a favorite of investors.

This is the largest global industry gathering for the orphan drug industry and rare disease community where pharma, biotech, patient groups, academia, regulators, payers and investors gather to talk about strategies to expedite orphan drug development. We grew the event to 600 participants in 2015 with over 25 countries represented. 

Academic medical centers, HCPs, clinicians and point of care diagnostics will be a new focus in 2016. Specific orphan products and their Marketing Managers will also be a stronger focus along with gene therapy as the future rare disease cure. 

Meet CEOs, VPs and Directors of the following business units from pharma and biotech: R&D, Business Development, Regulatory Access, Market Access, Commercial, Marketing and Brand/Product Managers.You will also meet Scientists, Investigators and Engineers as well as relevant Heads from university departments studying rare disease and developing a cure. 

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Hilton Washington   

Northwest Washington, 1919, Connecticut Avenue Northwest Washington, D.C. United States of America

Submission Info

World Orphan Drug Congress USA is the largest global orphan drug industry event. 

This event  is dedicated to fostering partnerships and collaboration amongst industry, governments, payers, investors and patients. It is about expediting orphan drug development and articulating its value, from discovery to patient access, so that manufacturers are guaranteed full and speedy reimbursement. 

The World Orphan Drug Congress USA is a place where innovation and expertise is showcased, solutions are found and learning is done. 

IF YOU’RE SERIOUS ABOUT MEETING INDUSTRY DECISION MAKERS THEN YOU SHOULD BE GIVING CONSIDERATION TO THE SPONSORSHIP PACKAGES AVAILABLE. 

SPONSORS GET EXCLUSIVE ACCESS TO CONFERENCE ATTENDEES.

Terrapinn

96 Spring Street, 

4th Floor

New York, NY 10012

Tel: +1 212 379 6322

Fax: +1 212 379 6319

enquiry.us@terrapinn.com